DBV Technologies SA logo

DBV Technologies SA

FRA:DBV (France)   Ordinary Shares
€ 0.52 (0%) Dec 20
At Loss
P/B:
1.24
Market Cap:
€ 64.32M ($ 67.09M)
Enterprise V:
€ 27.57M ($ 28.76M)
Volume:
-
Avg Vol (2M):
5.00K
Trade In:

Business Description

Description
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.
Name Current Vs Industry Vs History
Cash-To-Debt 5.72
Equity-to-Asset 0.58
Debt-to-Equity 0.15
Debt-to-EBITDA -0.08
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 28.14
9-Day RSI 37.53
14-Day RSI 41.41
6-1 Month Momentum % -47.12
12-1 Month Momentum % -73.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.22
Quick Ratio 2.22
Cash Ratio 1.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.6
Shareholder Yield % -5.84

Profitability Rank

Name Current Vs Industry Vs History
ROE % -95.84
ROA % -69.88
ROIC % -304
ROC (Joel Greenblatt) % -582.52
ROCE % -90.9

Financials (Next Earnings Date:2025-03-07 Est.)

FRA:DBV's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

DBV Technologies SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.963
Beta -1.05
Volatility % 59.65
14-Day RSI 41.41
14-Day ATR (€) 0.037935
20-Day SMA (€) 0.6176
12-1 Month Momentum % -73.29
52-Week Range (€) 0.4355 - 1.831
Shares Outstanding (Mil) 102.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DBV Technologies SA Filings

Filing Date Document Date Form
No Filing Data

DBV Technologies SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

DBV Technologies SA Frequently Asked Questions

What is DBV Technologies SA(FRA:DBV)'s stock price today?
The current price of FRA:DBV is €0.52. The 52 week high of FRA:DBV is €1.83 and 52 week low is €0.44.
When is next earnings date of DBV Technologies SA(FRA:DBV)?
The next earnings date of DBV Technologies SA(FRA:DBV) is 2025-03-07 Est..
Does DBV Technologies SA(FRA:DBV) pay dividends? If so, how much?
DBV Technologies SA(FRA:DBV) does not pay dividend.

Press Release

Subject Date
No Press Release